7.40
-0.25
(-3.27%)
As of 8:28:07 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-69,573.00
-18,717.00
10,439.00
-1,939.00
Investing Cash Flow
-6,105.00
-36,719.00
-15,524.00
-33.00
Financing Cash Flow
86,316.00
8,352.00
113,109.00
2,739.00
End Cash Position
53,907.00
65,466.00
112,346.00
4,322.00
Interest Paid Supplemental Data
3,668.00
321.00
218.00
78.00
Capital Expenditure
-258.00
-93.00
-102.00
-33.00
Issuance of Capital Stock
71,925.00
--
49,285.00
--
Issuance of Debt
62,620.00
12,800.00
--
3,084.00
Repayment of Debt
-47,431.00
-16.00
-38,097.00
-227.00
Repurchase of Capital Stock
--
-4,723.00
-2,814.00
--
Free Cash Flow
-69,645.00
-18,810.00
10,337.00
-1,972.00
12/31/2020 - 6/22/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CVAC.VI CureVac N.V.
3.6080
-3.84%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
0.00%
471A.F aTyr Pharma, Inc.
3.4200
+1.18%
2Q5.BE Enochian BioSciences Inc
0.8460
-0.24%
HQ1.MU Oruka Therapeutics Inc. R
11.80
-3.28%
PH4.F CStone Pharmaceuticals
0.2860
0.00%
ORN.F Oryzon Genomics S.A.
1.4660
+3.97%
4FR.BE Faron Pharmaceuticals Oy
2.1900
-0.90%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4700
-3.09%
25I.F ImmuPharma plc
0.0465
+106.67%